基本信息
产品编号: |
B10129 |
||||
产品名称: |
Biochanin A |
||||
CAS: |
491-80-5 |
储存条件 |
粉末 |
室温 |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
两年 |
||
分子量 |
284.26 |
-20℃ |
一个月 |
||
化学名: |
5,7-Dihydroxy-4'-methoxyisoflavone |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
56mg/mL (197.0mM) |
|||
Ethanol |
16mg/mL (56.28mM) |
||||
Water |
Insoluble |
||||
体内(现配现用): |
1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility: ≥ 2.5mg/mL (8.79mM); Clear solution |
||||
此⽅案可获得 ≥ 2.5mg/mL (8.79mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50μL Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 |
|||||
2.请依序添加每种溶剂:10% DMSO→90% corn oil Solubility: ≥ 2.5mg/mL (8.79mM); Clear solution |
|||||
此⽅案可获得 ≥ 2.5mg/mL (8.79mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 900μL ⽟⽶油中,混合均匀。 |
|||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
3.5179mL |
17.5895mL |
35.1791mL |
5mM |
0.7036mL |
3.5179mL |
7.0358mL |
10mM |
0.3518mL |
1.7590mL |
3.5179mL |
50mM |
0.0704mL |
0.3518mL |
0.7036mL |
生物活性
产品描述 |
Biochanin A (4-Methylgenistein) 是O-甲基异黄酮,是黄酮类的一种天然有机化合物。 |
|||
靶点 |
FAAH (rat) 1.4µM |
FAAH (mouse) 1.8µM |
FAAH (human) 2.4µM |
EGFR 91.5µM |
体外研究 |
Biochanin A被报到能够抑制表皮生长因子受体的蛋白酪氨酸激酶(PTK),IC50值为91.5µM。Biochanin A抑制小鼠、大鼠和人体内脂肪酸酰胺(FAAH)对0.5µM大麻素的水解作用,IC50值分别为1.8,1.4以及2.4µM。Biochanin A能够抑制血清和EGF刺激的LNCaP和DU-145细胞的生长(对血清的IC50值为8.0到27 微克/毫升,对EGF的IC50值为4.3到15微克/毫升),但是对EGF受体酪氨酸的自身磷酸化没有显著作用。 |
|||
体内研究 |
LD50:小鼠63毫克/千克(腹腔注射) |
推荐实验方法(仅供参考)
Kinase Assay |
For experiments with FAAH, rat liver homogenates, mouse brain homogenates and membranes from COS7 cells transfected with the human enzyme are used. Frozen (−80°C) livers from adult C57BL/6 mice and frozen brains (minus cerebella) from adult Wistar or Sprague-Dawley rats are thawed and homogenized in 20mM HEPES, 1mMmgCl2, pH 7. The homogenates are centrifuged at ~35000×g for 20 min at 4°C. After resuspension in buffer followed by recentrifugation and a second resuspension in buffer, the pellets are incubated at 37°C for 15 min. This incubation is undertaken in order to hydrolyse all endogenous FAAH substrates. The homogenates are then centrifuged as above, recentrifuged and resuspended in 50mM Tris-HCl buffer, pH 7.4, containing 1mM EDTA and 3mMmgCl2. The homogenates are then frozen at −80°C in aliquots until used for assay. FAAH is assayed in the homogenates and in the COS7 cell membranes using 0.5µM (unless otherwise stated) [ 3H]AEA labelled in the ethanolamine part of the molecule. Blank values are obtained by the use of buffer rather than homogenate. In the experiments comparing effects of Biochanin A upon FAAH and FAAH-2, the same assay is used but with 16 nM [3H]oleoylethanolamide ([3H]OEA) as substrate and with an incubation phase at room temperature. The choice of OEA rather than AEA for FAAH-2 is motivated by the relative rates of hydrolysis: OEA is metabolized four times faster than AEA by FAAH-2, whereas for FAAH the rate of hydrolysis of OEA is about a third of that for AEA. When 0.5µM [3H]AEA is used as substrate, assay conditions for rat brain and mouse liver are chosen so that <10% of added substrate is metabolized. For the human FAAH samples, <5% of the [3H]AEA is metabolized in all cases. For 16 nM [3H]OEA, a limited supply of an expensive ligand meant that optimization is not possible, and the amount of substrate utilized is higher (34±1 and 0.5±0.1% for FAAH and its corresponding mock-transfected, respectively; 40±2 and 21±0.4 for FAAH-2 and its corresponding mocktransfected respectively) |
|
|
Animal Administration |
Mice ICR mice are used for the behavioural tests measuring spontaneous activity (over a 10 min testing period), rectal temperature, ring immobility (over a 5 min testing period) and nociceptive threshold (tail flick tests). AEA and Biochanin A are dissolved in a vehicle consisting of ethanol, Emulphor-620 and physiological saline in a ratio of 1:1:18 v/v, and administered i.v. to the animals via the tail vein (injection volume 10µL/g body weight). The degree of antinociception is expressed as percentage of maximum possible effect (%MPE), defined as [(test-control time)/(10-control time)]×100. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )